Chancerne for at fastholde rygeophør efter uge 24 efter yderligere 12 ugers behandling med CHAMPIX var 2, 47 gange chancerne for placebo (p < 0, 0001).
The odds of maintaining abstinence at week 24, following an additional 12 weeks of treatment with CHAMPIX, were 2.47 times those for placebo (p < 0.0001).